195 related articles for article (PubMed ID: 30908997)
21. Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations.
Jung SW; Cho AE; Yu W
Sci Rep; 2018 Sep; 8(1):13787. PubMed ID: 30213978
[TBL] [Abstract][Full Text] [Related]
22. 3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.
Gade S; Mahmood S
J Pharm Bioallied Sci; 2012 Apr; 4(2):123-33. PubMed ID: 22557923
[TBL] [Abstract][Full Text] [Related]
23. Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.
Khedkar VM; Ambre PK; Verma J; Shaikh MS; Pissurlenkar RR; Coutinho EC
J Mol Model; 2010 Jul; 16(7):1251-68. PubMed ID: 20069323
[TBL] [Abstract][Full Text] [Related]
24. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
[TBL] [Abstract][Full Text] [Related]
25. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
26. Homology modeling and 3D-QSAR study of benzhydrylpiperazine δ opioid receptor agonists.
Pan C; Meng H; Zhang S; Zuo Z; Shen Y; Wang L; Chang KJ
Comput Biol Chem; 2019 Dec; 83():107109. PubMed ID: 31445419
[TBL] [Abstract][Full Text] [Related]
27. 3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods.
Purushottamachar P; Kulkarni VM
Bioorg Med Chem; 2003 Aug; 11(16):3487-97. PubMed ID: 12878142
[TBL] [Abstract][Full Text] [Related]
28. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
[TBL] [Abstract][Full Text] [Related]
29. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.
Lei B; Du J; Li S; Liu H; Ren Y; Yao X
J Comput Aided Mol Des; 2008 Oct; 22(10):711-25. PubMed ID: 18716715
[TBL] [Abstract][Full Text] [Related]
30. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs.
Wu HQ; Yao J; He QQ; Chen FE
SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254
[TBL] [Abstract][Full Text] [Related]
31. In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.
Kuang G; Hu G; Sun X; Li W; Liu G; Tang Y
J Mol Model; 2012 Aug; 18(8):3831-45. PubMed ID: 22402754
[TBL] [Abstract][Full Text] [Related]
32. Studies of cannabinoid-1 receptor antagonists for the treatment of obesity: hologram QSAR model for biarylpyrazolyl oxadiazole ligands.
Ye M; Dawson MI
Bioorg Med Chem Lett; 2009 Jun; 19(12):3310-5. PubMed ID: 19427207
[TBL] [Abstract][Full Text] [Related]
33. Multiple receptor conformation docking and dock pose clustering as tool for CoMFA and CoMSIA analysis - a case study on HIV-1 protease inhibitors.
Sivan SK; Manga V
J Mol Model; 2012 Feb; 18(2):569-82. PubMed ID: 21547550
[TBL] [Abstract][Full Text] [Related]
34. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
[TBL] [Abstract][Full Text] [Related]
35. CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists.
Cichero E; Cesarini S; Mosti L; Fossa P
J Mol Model; 2010 Sep; 16(9):1481-98. PubMed ID: 20174844
[TBL] [Abstract][Full Text] [Related]
36. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
37. Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.
Teixeira C; Gomes JR; Couesnon T; Gomes P
J Comput Aided Mol Des; 2011 Aug; 25(8):763-75. PubMed ID: 21786172
[TBL] [Abstract][Full Text] [Related]
38. Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.
Zhou YJ; Zhu LP; Tang Y; Ye DY
Eur J Med Chem; 2007 Jul; 42(7):977-84. PubMed ID: 17331624
[TBL] [Abstract][Full Text] [Related]
39. In silico profiling the interaction mechanism of 2,5-diketopiperazine derivatives as oxytocin antagonists.
Yang M; Luo J; Zeng Z; Yang L; Xu L; Li Y
J Mol Graph Model; 2019 Jun; 89():178-191. PubMed ID: 30904734
[TBL] [Abstract][Full Text] [Related]
40. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
Halim SA; Zaheer-ul-Haq
Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
